Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults-Reference-Cited by-同舟云学术

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults

Published:2015-10 Issue:10 Volume:5 Page:e008748
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Green C A,Scarselli E,Voysey M,Capone S,Vitelli A,Nicosia A,Cortese R,Thompson A J,Sande C S,de Lara Catherine,Klenerman P,Pollard A J

Publisher

BMJ

Subject

General Medicine

Reference44 articles.

1. Risk of primary infection and reinfection with respiratory syncytial virus;Glezen;Am J Dis Child,1986

2. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

3. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area;Deshpande;Arch Dis Child,2003

4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group;Pediatrics,1998

5. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid;Boyce;J Pediatr,2000

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2024-05-05

2. All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?;Vaccines;2024-01-18

3. Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice;Biomedicine & Pharmacotherapy;2024-01

4. Viral-vectored respiratory mucosal vaccine strategies;Current Opinion in Immunology;2023-10

5. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25